Most of the tests that doctors use to diagnose cancer are based on imaging. Cancer can also be found with molecular diagnostics, which can detect specific cancer-associated molecules that circulate in bodily fluids, such as blood and urine. Now, engineers at MIT have created a new diagnostic nanoparticle that combines both of these features: It can reveal the presence of cancerous proteins through a urine test, and it functions as an imaging agent, pinpointing the tumor location.
An official website of the United States government.